Nanjing Medical University at ASHG 2026
Oct 20–24, 2026 Montréal, Canada ~7.5k attendees Website
Nanjing Medical University brings 6 presentations from 2 research groups to ASHG 2026 in Montréal. Its program centres on cancer genetics, cancer prevention and reproductive health. The Center for Global Health brings transcriptomics of precancerous gastric lesions, while Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine brings a cross-population lung cancer meta-analysis.
| Organization | ASHG 2026 Attendance |
|---|---|
Nanjing Medical University Nanjing, China | 1 Faculty |
Center for Global Healthgwxy.njmu.edu.cn/2020/0604/c14817a171938/page.htm Coordinates environmental medicine, health systems and policy, infectious disease, personalized oncology, and reproductive-health research. Links Nanjing Medical University with Chinese CDC and other public-health institutions. No funding stated · No openings posted | Plenary Fri Oct 23 4:30 pm Transcriptomics profiling identifies signatures associated with progression of precancerous gastric lesions CancerCandidate geneGastrointestinal systemMachine learning |
Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine Works in cancer genetics. | Poster Wed Oct 21 2:30 pm Genome-wide meta-analysis across East Asian and European populations provides insights into the molecular basis of lung cancer Candidate geneDatabasesGenetic epidemiologyGenome-wide association study |
| 3 more presenters — research group not yet identified | |
Instantly find 20 buyers from Nanjing Medical University
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American Society of Human Genetics. Submit a correction